Rite Aid Corporation, a comprehensive pharmacy, has announced that it is initiating a strategic and value-maximizing sale process for substantially all of its assets. To facilitate this, the company and its subsidiaries have voluntarily filed for Chapter 11 bankruptcy protection in the U.S. Bankruptcy Court for the District of New Jersey. During the process, Rite Aid will continue to provide pharmacy services and products both in stores and online. The company is working to ensure a smooth transfer of customer prescriptions to other pharmacies while maintaining employee pay and benefits throughout the transition.
Chief Executive Officer Matt Schroeder emphasized, “As we move forward, our key priorities are ensuring uninterrupted pharmacy services for our customers and preserving jobs for as many associates as possible.” Rite Aid has secured commitments from existing lenders for $1.94 billion in new financing to support operations during the sale. This funding, along with operational revenue, is expected to sustain the business throughout the court-supervised process. The company plans to divest or monetize any remaining assets not sold through the proceedings. Rite Aid, which also operates Bartell Drugs, has filed standard motions with the court to continue business operations and pay employees. Schroeder expressed gratitude to the employees for their continued dedication and recognized the company’s longstanding role in serving community healthcare needs.
